Pictured: Ragupathi Lab

Tumor cells can be killed in the test tube and in mice by antibody or T cell-mediated mechanisms. The focus of our lab is on developing monoclonal antibodies, optimizing vaccines that induce antibody responses, and producing and testing new immunological adjuvants to augment these responses.

Pictured: Govind Ragupathi

Govind Ragupathi, PhD

Research Focus

Physician-scientist Govind Ragupathi studies tumor vaccinology, including approaches to augmenting the antibody and T cell response to defined cancer antigens.

Lab Members